Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Medical research stories

Oct 30, 2026

First patient receives Sumitomo Pharma stem cell transplant for Parkinson's disease

A patient has undergone pioneering stem-cell therapy to treat Parkinson's disease using Sumitomo Pharma's treatment, which involves transplanting millions of induced pluripotent stem (iPS) cells. This marks a world first following the treatment's conditional approval in Japan.

Oct 30, 2026·3 sources
00

Psoriasis patients face increased cataract risk, study finds

A study published in the Journal of Dermatology found that patients with psoriasis have an increased risk for cataracts and cataract surgery, with risks varying by treatment modality. The research was conducted by Yan-Jie Su from Taipei Veterans General Hospital in Taiwan.

Oct 30, 2026·2 sources
00

Cleveland Clinic study finds platelets may drive glioblastoma progression

New research published in Cancer Cell reveals that glioblastoma patients have more active platelets, which are blood clotting cells that also communicate with other cells and influence immune activity. The findings suggest platelets may play an unexpected role in the progression of this aggressive brain cancer.

Oct 30, 2026·4 sources
00

Female physicians linked to lower patient death and readmission rates, ICES study finds

A new ICES study led by University of Toronto researchers found that hospital patients treated by female physicians had lower mortality and readmission rates compared to those cared for by male physicians. The research, led by Dr. Angela Jerath, aims to improve patient outcomes by understanding differences in physician practice patterns.

Oct 30, 2026·3 sources
00

Norrin treatment prevents vision loss in diabetic rats, study finds

Research shows that treatment with norrin helps maintain healthy blood vessels in the retina and preserves vision in diabetic rats, offering potential hope for treating diabetic retinopathy, a complication affecting over 100 million people in the U.S.

Oct 30, 2026·2 sources
00

Blocking microRNA-31-5p interaction reverses heart scarring and atrial fibrillation in study

Researchers at Baylor College of Medicine and University of Oxford found that blocking a specific molecular interaction between microRNA-31-5p and calcitonin receptor reduced atrial fibrosis and abnormal heart rhythms in mouse models and human cells, offering a potential RNA-based therapeutic strategy for atrial fibrillation.

Oct 30, 2026·2 sources
00
Oct 29, 2026

University of Eastern Finland identifies vitamin transporter protein for brain drug delivery

Researchers at the University of Eastern Finland have identified the SMVT transporter protein that can improve creatine delivery to the brain and potentially enable new therapies targeting the central nervous system. The discovery addresses one of medicine's greatest challenges: delivering drugs across the blood-brain barrier.

Oct 29, 2026·4 sources
00

Major international studies identify accurate non-invasive tests for metabolic liver disease

Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Oct 29, 2026·3 sources
00

Researchers link linoleic acid breakdown product to psoriasis itch through GPR35 receptor

Scientists have discovered that EKODE, a metabolite of commonly consumed linoleic acid fat, binds to the GPR35 receptor to trigger inflammation and itching in psoriasis. Blocking this receptor in mouse models significantly reduced both inflammation and scratching behavior.

Oct 29, 2026·2 sources
00

International study identifies 127 genetic risk regions for Alzheimer's disease

A large-scale multi-ancestry genetic study led by Ole Andreassen at University of Oslo has identified new DNA risk factors for Alzheimer's disease, implicating microglial and neuronal dysregulation. The research reveals a larger common-variant contribution to the disease than previously estimated and identifies potential new drug targets.

Oct 29, 2026·3 sources
00
Oct 28, 2026

Mayo Clinic study finds deep brain stimulation produces measurable brain changes within 18 minutes in epilepsy patients

Mayo Clinic researchers detected measurable brain changes within 18 minutes of deep brain stimulation in patients with drug-resistant epilepsy, a finding that could help clinicians personalize treatment settings without waiting months to assess effectiveness.

Oct 28, 2026·2 sources
00

Heat waves increase stroke risk in older adults, University of São Paulo study finds

Research conducted in Brazil by University of São Paulo scientists found that each additional day of heat wave exposure in São Paulo is associated with increased acute stroke risk in people aged 65 and older. The study defined a heat wave as at least two consecutive days with maximum temperatures of 33.1°C (92°F) or higher.

Oct 28, 2026·3 sources
00
Oct 27, 2026

BYU researchers develop MOTO-CAR macrophage therapy to target solid tumors in preclinical study

Preclinical research demonstrates that macrophages can be programmed to fight solid cancer tumors, offering a potential new immunotherapy approach. The development comes as cancer kills one person every 50 seconds in the U.S., with some cancers continuing to resist current treatments.

Oct 27, 2026·2 sources
00

Mayo Clinic study finds cerebrospinal fluid liquid biopsy detects brain tumor DNA

A Mayo Clinic study published in the Journal of Neuro-Oncology demonstrates that analyzing DNA in cerebrospinal fluid can provide diagnostic information for brain tumors when MRI imaging is unclear or tissue biopsy is difficult or unsafe to obtain.

Oct 27, 2026·2 sources
00

University of Manchester researchers discover blood vessel defect in preeclampsia patients

Researchers at the University of Manchester and Manchester University NHS Foundation Trust have identified a previously hidden defect in the tiny blood vessels of women with preeclampsia, a dangerous pregnancy complication. The discovery, published in Circulation Research, could open the door to new treatments for the condition that threatens both mothers and babies.

Oct 27, 2026·2 sources
00
Oct 26, 2026

Heart drug combination reduces kidney damage in septic shock surgery, major trial finds

A major trial published in JAMA shows that a simple adjustment to drugs given during operations for septic shock could prevent thousands of patients from suffering kidney damage. Scientists from the University of Southampton and Zhejiang University School of Medicine conducted the research.

Oct 26, 2026·2 sources
00
Oct 22, 2026

Fruits and vegetables outperform sodium bicarbonate for treating metabolic acidosis in chronic kidney disease

A recent clinical trial found that dietary acid reduction using base-producing fruits and vegetables is more effective than the standard oral sodium bicarbonate treatment for metabolic acidosis in people with chronic kidney disease. The findings will be presented at ASN Kidney Week.

Oct 22, 2026·3 sources
00

Earlier survivorship care linked to lower risk of head and neck cancer recurrence and death

A University of Pittsburgh study published in JAMA Otolaryngology–Head & Neck Surgery found that head and neck cancer patients who participated in multidisciplinary survivorship clinics earlier experienced better survival rates and lower cancer recurrence compared to those who began survivorship care later.

Oct 22, 2026·2 sources
00

Flinders University study warns hospital handbasin design poses infection risk

Research published in the Journal of Hospital Infection warns that contaminated handbasins in healthcare facilities may put patients at risk and contribute to superbug outbreaks. The Flinders University review compares healthcare basin designs and their potential role in hospital-acquired infections.

Oct 22, 2026·2 sources
00

McGill study links multiple schizophrenia symptoms to single brain signal

A new imaging study published in Science Advances has identified a single brain signal that may explain several distinct symptoms of schizophrenia, including altered perception, behavior, and speech patterns. The research suggests these seemingly separate problems may share a common neurological basis.

Oct 22, 2026·2 sources
00
Oct 17, 2026

DOGE disruptions upended NIH's $112 million epidemiology contract, health officials say

Health officials report that disruptions caused by DOGE (Department of Government Efficiency) interfered with the National Institutes of Health's plans to award a $112 million follow-on contract for epidemiological studies, affecting a decade-old agreement that was set for competitive bidding.

Oct 17, 2026·1 source
00
Oct 2, 2026

TTHealthWatch podcast covers new treatment target for asthma and COPD

The weekly podcast from Texas Tech University features discussion of a new therapeutic target for asthma and chronic obstructive pulmonary disease, along with other top medical stories. The podcast is co-hosted by Elizabeth Tracey of Johns Hopkins Medicine and Dr. Rick Lange of Texas Tech Health El Paso.

Oct 2, 2026·3 sources
00
Sep 17, 2026

Systemic lupus erythematosus linked to increased risk for stroke

A systematic review found that systemic lupus erythematosus (SLE) is associated with an increased risk for stroke, including both ischemic and hemorrhagic stroke types.

Sep 17, 2026·1 source
00
Jun 26, 2026

GLP-1 Drugs Linked to Smell and Taste Impairment in Diabetes Patients

New research has identified a connection between GLP-1 medications and impairment of smell and taste in diabetes patients, adding to the growing list of side effects associated with this drug class.

Jun 26, 2026·1 source
00
Jun 17, 2026

GLP-1 Diabetes Drugs Linked to Smell and Taste Impairment, Study Finds

New research published in JAMA Otolaryngology analyzing health records from nearly 900,000 patients suggests long-term use of GLP-1 drugs like Ozempic and Mounjaro for diabetes management is associated with increased risks of smell and taste disturbances, though experts note these side effects are not common.

Jun 17, 2026·4 sources
00
May 8, 2026

Study Finds Fraudulent Citations Increasingly Common in Medical Research Papers

A new study reveals that fabricated citations that do not reference real academic papers are spreading in medical literature, with researchers attributing the problem partly to AI hallucinations. The trend is polluting the scientific record.

May 8, 2026·3 sources
00
May 6, 2026

Duke University Develops Gene Therapy to Help Hearts Heal After Heart Attacks

Researchers at Duke University are developing a gene therapy treatment designed to help repair heart damage following heart attacks, potentially changing how doctors treat cardiac injury from the leading cause of death in the U.S.

May 6, 2026·1 source
00
Apr 30, 2026

Partial Meniscectomy Knee Surgery Shows No Benefit and May Be Harmful in 10-Year Follow-Up Study

A 10-year follow-up of the FIDELITY placebo-surgery controlled trial published in the New England Journal of Medicine reveals that partial meniscectomy, one of the world's most common knee surgeries, does not improve patient symptoms or function.

Apr 30, 2026·1 source
00
Apr 18, 2026

Blood Pressure Drug Shows Effectiveness Against Antibiotic-Resistant Bacteria

Research published in Nature Communications reveals that a common blood pressure medication can effectively treat infections from antibiotic-resistant bacteria, offering a potential new weapon against drug-resistant infections responsible for over 35,000 U.S. deaths annually.

Apr 18, 2026·1 source
00

Top claims

  • ▪Parkinson's cell therapy developer Aspen Neuroscience raised $140.6 million in its initial public offering, selling 9.4 million shares at $15 each
  • ▪Sumitomo Pharma plans to perform induced pluripotent stem cell transplants on 20 to 30 Parkinson's disease patients by March 2029 while conducting a clinical trial in the United States.
  • ▪Aspen Neuroscience's experimental therapy sasineprocel modifies skin cells harvested from individual Parkinson's patients into autologous precursor cells to replenish dopamine-producing neurons.

Subtopics

Drug Policy, Pricing & Approval8Drug Approval and Clinical Trials7Biomedical research5Cancer & Oncology4Cancer research4Cardiovascular diseases4Clinical trials4Neuroscience4Autoimmune disease3Drug development3Cancer treatment2Clinical guidelines2Diagnostic imaging2Diagnostic medicine2Drug discovery2Epidemiology2GLP-1 / Weight-Loss Medications2GLP-1 medications2Immunotherapy2Lifestyle, Wellness and Nutrition2Neurodegenerative disease2Neurological disorders2Nutrition2Observational research2

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories